We observed no significant between-group difference in the intensity of LBP at one year ( MD 0.7 ; 95 % CI -1.0 to 2.4 ) or in secondary outcomes at any time point except that 20 % of patients in the ZA group used non-steroidal anti-inflammatory drugs at one year compared to 60 % in the placebo group ( P = 0.022 ) .